Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis
dc.contributor.author | Phillips, Helen M. | |
dc.contributor.author | Stothard, Catherine A. | |
dc.contributor.author | Qureshi, Wasay M. Shaikh | |
dc.contributor.author | Kousa, Anastasia L. | |
dc.contributor.author | Briones-Leon, J. Alberto | |
dc.contributor.author | Khasawneh, Ramada R. | |
dc.contributor.author | O'Loughlin, Chloe | |
dc.contributor.author | Sanders, Rachel | |
dc.contributor.author | Mazzotta, Silvia | |
dc.contributor.author | Dodds, Rebecca | |
dc.contributor.author | Seidel, Kerstin | |
dc.contributor.author | Bates, Timothy C | |
dc.contributor.author | Nakatomi, Mitsushiro | |
dc.contributor.author | Cockell, Simon J. | |
dc.contributor.author | Schneider, Jurgen E. | |
dc.contributor.author | Mohun, Timothy J. | |
dc.contributor.author | Maehr, Rene' | |
dc.contributor.author | Kist, Ralf | |
dc.contributor.author | Peters, Heiko | |
dc.contributor.author | Bamforth, Simon D. | |
dc.date.accessioned | 2023-04-21T23:09:39Z | |
dc.date.available | 2023-04-21T23:09:39Z | |
dc.date.issued | 2019-09 | |
dc.identifier | 220044515 | |
dc.identifier | 1b76b5ce-5d10-4594-bb4a-2ba6efa2ddba | |
dc.identifier | 85072583767 | |
dc.identifier.citation | Phillips , H M , Stothard , C A , Qureshi , W M S , Kousa , A L , Briones-Leon , J A , Khasawneh , R R , O'Loughlin , C , Sanders , R , Mazzotta , S , Dodds , R , Seidel , K , Bates , T C , Nakatomi , M , Cockell , S J , Schneider , J E , Mohun , T J , Maehr , R , Kist , R , Peters , H & Bamforth , S D 2019 , ' Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis ' , Development , vol. 146 , no. 18 , dev177618 . https://doi.org/10.1242/dev.177618 | en |
dc.identifier.issn | 0950-1991 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/19525 | |
dc.description | Funding British Heart Foundation (PG/14/28/30774) Consejo Nacional de Ciencia y Tecnología, Guatemala (NO AWARD) Newcastle upon Tyne Hospitals NHS Foundation Trust (BH120404) Yarmouk University (NO AWARD) | en |
dc.format.extent | 29660186 | |
dc.language.iso | eng | |
dc.relation.ispartof | Development | en |
dc.subject | Pharyngeal endoderm | en |
dc.subject | Arch artery development | en |
dc.subject | Tbx1 | en |
dc.subject | Pax9 | en |
dc.subject | Neural crest | en |
dc.subject | 22q11 deletion syndrome | en |
dc.subject | R Medicine | en |
dc.subject | British Heart Foundation | en |
dc.subject | PG/14/28/30774 | en |
dc.subject | Other | en |
dc.subject | Newcastle upon Tyne Hospitals NHS Foundation Trust (BH120404) | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1242/dev.177618 | |
dc.identifier.url | https://journals.biologists.com/dev/article/146/18/dev177618/224210/Pax9-is-required-for-cardiovascular-development?searchresult=1 | en |
dc.identifier.vol | 146 | en |
dc.identifier.iss | 18 | en |